AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
Log in

NYSE:ANTMAnthem Stock Price, Forecast & News

$255.00
0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$253.75
Now: $255.00
$257.00
50-Day Range
$255.00
MA: $273.80
$300.59
52-Week Range
$171.03
Now: $255.00
$312.48
Volume982,178 shs
Average Volume1.86 million shs
Market Capitalization$64.29 billion
P/E Ratio13.81
Dividend Yield1.49%
Beta0.95
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2018, it served 40 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Read More
Anthem logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.70 out of 5 stars


Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP94973V10
Phone800-331-1476

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$104.21 billion
Cash Flow$23.72 per share
Book Value$125.13 per share

Profitability

Net Income$4.81 billion

Miscellaneous

Employees70,600
Market Cap$64.29 billion
Next Earnings Date7/29/2020 (Confirmed)
OptionableOptionable

Receive ANTM News and Ratings via Email

Sign-up to receive the latest news and ratings for ANTM and its competitors with MarketBeat's FREE daily newsletter.

Anthem (NYSE:ANTM) Frequently Asked Questions

How has Anthem's stock been impacted by COVID-19 (Coronavirus)?

Anthem's stock was trading at $281.69 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ANTM shares have decreased by 9.5% and is now trading at $255.00. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Anthem?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Anthem in the last year. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Anthem.

When is Anthem's next earnings date?

Anthem is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Anthem.

How can I listen to Anthem's earnings call?

Anthem will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Anthem's earnings last quarter?

Anthem Inc (NYSE:ANTM) released its quarterly earnings results on Wednesday, April, 29th. The company reported $6.48 EPS for the quarter, missing the Zacks' consensus estimate of $6.54 by $0.06. The business earned $29.45 billion during the quarter, compared to analyst estimates of $28.63 billion. Anthem had a return on equity of 16.38% and a net margin of 4.38%. Anthem's quarterly revenue was up 20.7% compared to the same quarter last year. During the same period last year, the company posted $6.03 earnings per share. View Anthem's earnings history.

How often does Anthem pay dividends? What is the dividend yield for Anthem?

Anthem declared a quarterly dividend on Thursday, April 30th. Shareholders of record on Wednesday, June 10th will be paid a dividend of $0.95 per share on Thursday, June 25th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend is Tuesday, June 9th. View Anthem's dividend history.

What guidance has Anthem issued on next quarter's earnings?

Anthem updated its FY 2020 IntraDay earnings guidance on Tuesday, June, 9th. The company provided EPS guidance of 22.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $22.22.

What price target have analysts set for ANTM?

17 equities research analysts have issued twelve-month price objectives for Anthem's stock. Their forecasts range from $262.00 to $423.00. On average, they expect Anthem's share price to reach $335.20 in the next year. This suggests a possible upside of 31.5% from the stock's current price. View analysts' price targets for Anthem.

Has Anthem been receiving favorable news coverage?

News stories about ANTM stock have trended negative this week, InfoTrie reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Anthem earned a news impact score of -2.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. View the latest news about Anthem.

Are investors shorting Anthem?

Anthem saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 2,460,000 shares, a drop of 19.6% from the June 15th total of 3,060,000 shares. Based on an average trading volume of 1,680,000 shares, the days-to-cover ratio is presently 1.5 days. Approximately 1.0% of the shares of the company are short sold. View Anthem's Current Options Chain.

Who are some of Anthem's key competitors?

What other stocks do shareholders of Anthem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anthem investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Alibaba Group (BABA), Visa (V), Walt Disney (DIS), Boeing (BA), Netflix (NFLX), Intel (INTC), Johnson & Johnson (JNJ) and Mastercard (MA).

Who are Anthem's key executives?

Anthem's management team includes the following people:
  • Ms. Gail Koziara Boudreaux, Pres, CEO & Director (Age 58)
  • Mr. John Edward Gallina, Exec. VP & CFO (Age 59)
  • Ms. Gloria Marie McCarthy, Exec. VP and Chief Admin. & Transformation Officer (Age 66)
  • Mr. Thomas Casimir Zielinski Jr., Exec. VP & Gen. Counsel (Age 68)
  • Mr. Peter David Haytaian, Exec. VP and Pres of Commercial & Specialty Bus. Division (Age 49)

What is Anthem's stock symbol?

Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."

Who are Anthem's major shareholders?

Anthem's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.05%), Envestnet Asset Management Inc. (0.05%), Whittier Trust Co. (0.04%), State of Alaska Department of Revenue (0.02%), Moody National Bank Trust Division (0.02%) and DNB Asset Management AS (0.01%). Company insiders that own Anthem stock include Craig E Samitt, Gail Boudreaux, Gloria M Mccarthy, Julie A Hill, Peter D Haytaian, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View institutional ownership trends for Anthem.

Which major investors are selling Anthem stock?

ANTM stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Fulton Bank N. A., Municipal Employees Retirement System of Michigan, DNB Asset Management AS, Farmers & Merchants Trust Co of Chambersburg PA, Diversified Trust Co, Copperleaf Capital LLC, and IBM Retirement Fund. Company insiders that have sold Anthem company stock in the last year include Gloria M Mccarthy, Julie A Hill, Peter D Haytaian, Robert L Dixon Jr, Ronald W Penczek, and Thomas C Zielinski. View insider buying and selling activity for Anthem.

Which major investors are buying Anthem stock?

ANTM stock was purchased by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Envestnet Asset Management Inc., Whittier Trust Co., Cypress Capital Group, First American Trust FSB, Global Trust Asset Management LLC, Sanders Morris Harris LLC, and Summit Financial Group Inc.. View insider buying and selling activity for Anthem.

How do I buy shares of Anthem?

Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Anthem's stock price today?

One share of ANTM stock can currently be purchased for approximately $255.00.

How big of a company is Anthem?

Anthem has a market capitalization of $64.29 billion and generates $104.21 billion in revenue each year. The company earns $4.81 billion in net income (profit) each year or $19.44 on an earnings per share basis. Anthem employs 70,600 workers across the globe.

What is Anthem's official website?

The official website for Anthem is www.antheminc.com.

How can I contact Anthem?

Anthem's mailing address is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 800-331-1476 or via email at [email protected]

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.